Tadalafil Dosing Recommendations
For erectile dysfunction, start tadalafil at 10 mg as needed (taken prior to sexual activity) or 2.5 mg daily; for benign prostatic hyperplasia, use 5 mg daily; and for pulmonary arterial hypertension, use 40 mg once daily—with critical dose reductions required for severe renal or hepatic impairment. 1
Erectile Dysfunction (ED)
As-Needed Dosing
- Starting dose: 10 mg taken prior to anticipated sexual activity 1
- Dose range: 5-20 mg based on individual efficacy and tolerability 1
- Maximum frequency: Once per day 1
- Duration of action: Up to 36 hours, which should be considered when counseling patients 1
The 2018 AUA Guideline strongly recommends PDE5 inhibitors as first-line therapy for ED, emphasizing that dose titration is essential to optimize efficacy 2. All PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) show similar efficacy in the general ED population, though patients with diabetes or post-prostatectomy status respond less robustly 2.
Daily Dosing for ED
- Starting dose: 2.5 mg daily taken at approximately the same time each day 1
- May increase to 5 mg daily based on efficacy and tolerability 1
- Timing: Independent of sexual activity 1
Daily dosing produces equivalent efficacy to on-demand dosing 2. This regimen is particularly useful for men who anticipate frequent sexual activity.
Benign Prostatic Hyperplasia (BPH)
Recommended dose: 5 mg once daily taken at approximately the same time every day 1
When initiating combination therapy with finasteride for BPH, maintain tadalafil 5 mg daily for up to 26 weeks 1. The 2025 EAU Guidelines note that daily tadalafil 5 mg demonstrated lower curvature progression rates in Peyronie's disease and improved BPH symptoms 3.
Key advantage: Tadalafil is the only medication that simultaneously treats both ED and LUTS/BPH, avoiding the sexual dysfunction side effects associated with alpha-blockers and 5-alpha reductase inhibitors 4, 5.
Combined ED and BPH
Recommended dose: 5 mg once daily taken at approximately the same time each day, without regard to timing of sexual activity 1
This single dose addresses both conditions effectively, making it particularly valuable in aging men where these conditions commonly coexist 4, 6, 5.
Pulmonary Arterial Hypertension (PAH)
Recommended dose: 40 mg once daily 7, 8
Critical warning: Treatment with more than 40 mg daily has not been studied and is NOT recommended 7. The 2014 CHEST Guidelines suggest tadalafil to improve 6-minute walk distance, WHO functional class, delay time to clinical worsening, and improve cardiopulmonary hemodynamics (Grade 2B-2C evidence) 7.
Important contraindication: Male patients treated with riociguat for PAH should be cautioned NOT to use PDE5 inhibitors for erectile dysfunction due to risk of systemic hypotension 7.
Dose Adjustments for Renal Impairment
As-Needed Dosing
- CrCl 30-50 mL/min: Start with 5 mg, maximum 10 mg once every 48 hours 1
- CrCl <30 mL/min or hemodialysis: Maximum 5 mg once every 72 hours 1
Daily Dosing
- ED with CrCl <30 mL/min or hemodialysis: Daily dosing NOT recommended 1
- BPH or ED/BPH with CrCl 30-50 mL/min: Start with 2.5 mg daily, may increase to 5 mg based on response 1
- BPH or ED/BPH with CrCl <30 mL/min or hemodialysis: Daily dosing NOT recommended 1
Dose Adjustments for Hepatic Impairment
As-Needed Dosing
- Mild-moderate (Child-Pugh A or B): Maximum 10 mg once per day; use caution 1
- Severe (Child-Pugh C): Tadalafil NOT recommended 1
Daily Dosing
- Mild-moderate (Child-Pugh A or B): Use with caution; not extensively studied 1
- Severe (Child-Pugh C): Tadalafil NOT recommended 1
The 2018 AUA Guideline emphasizes that in men with mild to moderate hepatic or renal impairment, PDE5 inhibitors should be used cautiously at lower initial doses due to potential for delayed metabolism 2.
Critical Drug Interactions and Contraindications
Absolute Contraindications
- Nitrates in any form: Concomitant use is absolutely contraindicated 1
Potent CYP3A4 Inhibitors
- As-needed dosing: Maximum 10 mg, not to exceed once every 72 hours when taking ketoconazole or ritonavir 1
- Daily dosing: Maximum 2.5 mg daily when taking potent CYP3A4 inhibitors 1
Alpha-Blockers
- For ED: Patients should be stable on alpha-blocker therapy before initiating tadalafil at the lowest recommended dose 1
- For BPH: Tadalafil is NOT recommended in combination with alpha-blockers 1
Administration and Patient Counseling
Food: May be taken without regard to food 1
Critical counseling points per the 2018 AUA Guideline 2:
- Sexual stimulation is necessary for efficacy
- More than one trial may be required to establish efficacy
- Avoid taking with large meals (can delay absorption)
- Common adverse events include headache, flushing, dyspepsia, back pain, nasal congestion, and myalgia
- Tadalafil has the lowest rates of flushing compared to other PDE5 inhibitors 2
Special Populations
Diabetes and post-prostatectomy patients: These men have more severe ED at baseline and respond less robustly to PDE5 inhibitors, often requiring higher doses or combination therapy 2.
Testosterone deficiency: Men with ED and hypogonadism should be informed that PDE5 inhibitors are more effective when combined with testosterone therapy, though testosterone alone is not effective for ED 2.
Cardiovascular disease: ED is a strong independent risk marker for cardiovascular disease; the diagnosis provides an opportunity to discuss cardiovascular risk and initiate appropriate referrals 2.
Common Pitfalls to Avoid
- Do not split tablets—the entire dose should be taken 1
- Do not exceed 40 mg daily for PAH—higher doses are unstudied and potentially dangerous 7
- Do not combine with alpha-blockers for BPH treatment—use one or the other 1
- Do not use in severe renal or hepatic impairment—contraindicated 1
- Do not assume treatment failure after one dose—multiple trials may be needed, and dose titration is essential 2